Surglasses - Taiwan Main Orthopaedic Biotechnology Co., Ltd. logo — Evolution in Surgery

Surglasses - Taiwan Main Orthopaedic Biotechnology Co., Ltd.

Evolution in Surgery

Founded 2017 Taiwan Taiwan 11 employees Seed Total: $6.50M Biotechnology, Health Care +2

General Information

Company Name Surglasses - Taiwan Main Orthopaedic Biotechnology Co., Ltd.
Founded Year 2017
Location Taiwan Taiwan +1
Employees 11
Industries Biotechnology, Health Care, Manufacturing +1
Funding Stage Seed
Social

Get notified when Surglasses - Taiwan Main Orthopaedic Biotechnology Co., Ltd. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Surglasses - Taiwan Main Orthopaedic Biotechnology Co., Ltd.

Surglasses is a pioneering medical company that is revolutionizing the future of surgical and educational tools. They are integrating advanced technology to enhance medical outcomes and experiences worldwide. The company is focused on developing and marketing innovative products for medical education and surgical navigation solutions. With patented technology, SURGLASSES offers high-performance surgical systems and educational tools. Their manufacturing site in Taichung, Taiwan is certified with CE Mark, ISO-13485, and GMP, producing a range of FDA and CE approved medical equipment aimed at surgical and educational applications. Their product line provides a versatile and cost-effective alternative for surgical planning and guiding tools. The company aims to capture a significant share of the international market by developing creative solutions in medical products. Surglasses brings top-tier technology to the medical, surgical, clinical, and health sectors, improving outcomes through continuous R&D. They strive to meet the needs of surgeons, physicians, patients, caregivers, and educators with their advanced medical solutions. At Taiwan Main Orthopedic Biotechnology, their goal is to lead advancements in medical electronics, minimally invasive surgery, intelligent medical informatics, real-time medical data digitization & information visualization, surgical navigation, medical augmented reality (AR), and mixed reality (MR). The company's key products include Foresee-X and Caduceus. Foresee-X is the first CE-approved smart surgical glasses featuring augmented reality technology for visualized medical imaging during surgery. Caduceus offers precise spine surgical navigation with 3D mixed reality. Surglasses was founded in 2017 and has received a recent investment of $6.50M in a Seed Round on 09 November 2023. The investors in this round include 500 Startups, Integrated Capital, Sustainable Impact Capital, Taiwania Capital Management Corporation, and Wisdom Capital. The company operates in the Biotechnology, Health Care, and Manufacturing industries.

Taxonomy: Medical Technology, Surgical Navigation, Augmented Reality, Mixed Reality, Medical Education Tools, Medical Imaging, Surgical Equipment, Innovative Products, CE Mark, ISO-13485, GMP Certification, Medical Electronics, Minimally Invasive Surgery, Real-Time Medical Data, Medical Informatics

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round •••••• 5
Investor Investor Investor Investor Investor
09 Nov 2023

Surglasses - Taiwan Main Orthopaedic Biotechnology Co., Ltd. Alternatives & Competitors

Surglasses - Taiwan Main Orthopaedic Biotechnology Co., Ltd. vs

Leading brand of operating room equipment solutions and the expert of UVC disinfection robot.

29 employees
Manufacturing, Retail
Surglasses - Taiwan Main Orthopaedic Biotechnology Co., Ltd. vs

Smart Assistant Surgeon Through Augmented Reality Solutions

Pre Seed
3 employees
Analytics, Biotechnology
Surglasses - Taiwan Main Orthopaedic Biotechnology Co., Ltd. vs
SynDaver
SynDaver United States

Beyond Human

46 employees
Biotechnology

FAQ About Surglasses - Taiwan Main Orthopaedic Biotechnology Co., Ltd.

Evolution in Surgery
Surglasses - Taiwan Main Orthopaedic Biotechnology Co., Ltd. was founded in 2017.
Surglasses - Taiwan Main Orthopaedic Biotechnology Co., Ltd. is headquartered in Taiwan.
Surglasses - Taiwan Main Orthopaedic Biotechnology Co., Ltd. operates in the following industries: Biotechnology, Health Care, Manufacturing, Medical Devices.
Surglasses - Taiwan Main Orthopaedic Biotechnology Co., Ltd. has approximately 11 employees.
Surglasses - Taiwan Main Orthopaedic Biotechnology Co., Ltd. has completed 1 funding round, raising a total of $6.50M. The latest funding stage is Seed.
Top alternatives and competitors to Surglasses - Taiwan Main Orthopaedic Biotechnology Co., Ltd. include Mediland Enterprise Corporation, Intravides, SynDaver, Integritech, CP Medical, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Surglasses - Taiwan Main Orthopaedic Biotechnology Co., Ltd. and Mediland Enterprise Corporation are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Surglasses - Taiwan Main Orthopaedic Biotechnology Co., Ltd. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes